» Articles » PMID: 16645454

Mechanisms Underlying the QT Interval-prolonging Effects of Sevoflurane and Its Interactions with Other QT-prolonging Drugs

Overview
Journal Anesthesiology
Specialty Anesthesiology
Date 2006 Apr 29
PMID 16645454
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sevoflurane prolongs ventricular repolarization in patients, but the mechanisms are not fully characterized. The effects of sevoflurane on many cloned human cardiac ion channels have not been studied, and the interactions between sevoflurane and other drugs that prolong cardiac repolarization have not been detailed.

Methods: The effects of sevoflurane on action potentials and L-type Ca channels in guinea pig myocytes were examined. Sevoflurane's effects on cloned human cardiac K channels and the cloned human cardiac Na channel were studied. The consequences of combining sevoflurane and the class III antiarrhythmic drugs sotalol or dofetilide on action potential duration were also examined.

Results: Sevoflurane produced an increase in action potential duration at concentrations of 0.3-1 mm. Contrary to most drugs that delay ventricular repolarization, sevoflurane was without effect on the human ether-a-go-go-related gene cardiac potassium channel but instead produced a reduction in KvLQT1/minK K channel currents and inhibited the Kv4.3 K channel by speeding its apparent rate of inactivation. Sevoflurane had little effect on Na and Ca channel currents at concentrations of 1 mm or less. When the authors coadministered sevoflurane with sotalol or dofetilide, synergistic effects on repolarization were observed, resulting in large increases in action potential duration (up to 66%).

Conclusion: Prolonged ventricular repolarization observed with administration of sevoflurane results from inhibition of KvLQT1/minK and Kv4.3 cardiac K channels. Combining sevoflurane with class III antiarrhythmic drugs results in supra-additive effects on action potential duration. The results indicate that sevoflurane, when administered with this class of drug, could result in excessive delays in ventricular repolarization. The results suggest the need for further clinical studies.

Citing Articles

Sustained mitigation of ST-segment elevation in a patient with Brugada syndrome type 1 during sevoflurane and remifentanil anesthesia: a case report.

Saito K, Yoshida H, Hirota K JA Clin Rep. 2024; 10(1):18.

PMID: 38467908 PMC: 10928048. DOI: 10.1186/s40981-024-00702-7.


Prediction of anesthetic torsadogenicity using a human ventricular cell model.

Kojima A, Fukushima Y, Matsuura H J Anesth. 2023; 37(5):806-810.

PMID: 37524993 DOI: 10.1007/s00540-023-03238-9.


Cardiac Arrest Following Torsades de Pointes Caused by Hypokalemia and Catecholamines in a Patient with Congenital Long QT Syndrome Type 1 After Surgical Aortic Valve Replacement: A Case Report.

Kitaura A, Nakao S, Yuasa H, Tsukimoto S, Nakajima Y Am J Case Rep. 2022; 23:e938609.

PMID: 36523136 PMC: 9764086. DOI: 10.12659/AJCR.938609.


Open-channel blocking action of volatile anaesthetics desflurane and sevoflurane on human voltage-gated K 1.5 channel.

Fukushima Y, Kojima A, Mi X, Ding W, Kitagawa H, Matsuura H Br J Pharmacol. 2020; 177(16):3811-3827.

PMID: 32436224 PMC: 7393063. DOI: 10.1111/bph.15105.


The effects of intravenous anesthetics on QT interval during anesthetic induction with desflurane.

Tominaga S, Terao Y, Urabe S, Ono M, Oji N, Oji M JA Clin Rep. 2020; 4(1):57.

PMID: 32025881 PMC: 6967065. DOI: 10.1186/s40981-018-0195-9.